Login to Your Account



Tools Firm Illumina Considers Roche's Unsolicited $5.7B Bid

By Catherine Shaffer
BioWorld Today Contributing Writer

Thursday, January 26, 2012

The board of directors for Illumina Inc. is mulling over an unsolicited acquisition offer by Roche AG, of Basel, Switzerland, to purchase all outstanding shares in the San Diego-based genomics tools giant for $5.7 billion, or $44.50 per share in cash.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription